95 related articles for article (PubMed ID: 3352817)
1. [Problems with high-dose estrogen/progestin combinations such as Mestrogen, in India].
Wolffers I
Ned Tijdschr Geneeskd; 1988 Jan; 132(1):29-31. PubMed ID: 3352817
[No Abstract] [Full Text] [Related]
2. [Problems related to high-dose estrogen/progestogen combinations, such as Menstrogen, in India].
van Keep PA
Ned Tijdschr Geneeskd; 1988 Feb; 132(8):364-5. PubMed ID: 3362255
[No Abstract] [Full Text] [Related]
3. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
Wooltorton E
CMAJ; 2006 Jan; 174(2):164-5. PubMed ID: 16368722
[No Abstract] [Full Text] [Related]
4. [The use of limovanil in pregnancy].
Gardó S
Orv Hetil; 1977 Mar; 118(11):660. PubMed ID: 846706
[No Abstract] [Full Text] [Related]
5. Lower- vs higher-dose estrogen for contraception.
Kripke C
Am Fam Physician; 2005 Oct; 72(7):1224-5. PubMed ID: 16229072
[No Abstract] [Full Text] [Related]
6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
7. First chewable oral contraceptive.
FDA Consum; 2004; 38(2):4. PubMed ID: 15101351
[No Abstract] [Full Text] [Related]
8. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL
Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463
[No Abstract] [Full Text] [Related]
9. Continuous oral contraception. Strategies for managing breakthrough bleeding.
Freeman SB
Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
[No Abstract] [Full Text] [Related]
10. [Hormonal contraceptive patch].
Lidegaard O
Ugeskr Laeger; 2004 Oct; 166(41):3591. PubMed ID: 15515462
[No Abstract] [Full Text] [Related]
11. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
Cremer P; Vekemans M
Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
[No Abstract] [Full Text] [Related]
12. Desogestrel--a new progestin for oral contraception.
Med Lett Drugs Ther; 1993 Aug; 35(902):73-4. PubMed ID: 8336641
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of a new oral contraceptive containing drospirenone.
Shulman LP
J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
[TBL] [Abstract][Full Text] [Related]
14. [Genital hemorrhage in early pregnancy].
Staemmler HJ
Dtsch Med Wochenschr; 1973 Sep; 98(36):1683. PubMed ID: 4741245
[No Abstract] [Full Text] [Related]
15. [Risks of postcoital contraception using a d-norgestrel-ethinyl estradiol combination].
Welti H; Nguyen Duy N; Zufferey MM
Ther Umsch; 1986 May; 43(5):438-40. PubMed ID: 3726780
[No Abstract] [Full Text] [Related]
16. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
17. Less estrogen in new oral contraceptive.
Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
[No Abstract] [Full Text] [Related]
18. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Urdinola J
Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
[No Abstract] [Full Text] [Related]
19. Hormonal pregnancy tests and spina bifida.
Sever LE
Nature; 1973 Apr; 242(5397):410-1. PubMed ID: 4573581
[No Abstract] [Full Text] [Related]
20. Mircette: a novel oral contraceptive. Introduction.
Speroff L
Am J Obstet Gynecol; 1998 Jul; 179(1):S1. PubMed ID: 9704811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
